SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-102811
Filing Date
2019-04-10
Accepted
2019-04-10 16:10:55
Documents
7
Effectiveness Date
2019-04-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A d704759ddefa14a.htm DEFA14A 40799
2 GRAPHIC g704759dsp003.jpg GRAPHIC 1136
3 GRAPHIC g704759dsp004b.jpg GRAPHIC 1552
4 GRAPHIC g704759dsp004c.jpg GRAPHIC 1143
5 GRAPHIC g704759dsp004d.jpg GRAPHIC 3167
6 GRAPHIC g704759dsp005b.jpg GRAPHIC 1179
7 GRAPHIC g704759dsp006.jpg GRAPHIC 1142
  Complete submission text file 0001193125-19-102811.txt   55590
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36152 | Film No.: 19741792
SIC: 2836 Biological Products, (No Diagnostic Substances)